Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Angel Oak Financial Strategies | FINS | Sep 19, 2024 | 13.16 | -0.08 |
Angel Oak Mortgage REIT | AOMR | Sep 19, 2024 | 10.57 | +1.25 |
Anghami | ANGH | Sep 19, 2024 | 0.88 | -0.46 |
Angi A | ANGI | Sep 19, 2024 | 2.84 | +2.53 |
AngioDynamics | ANGO | Sep 19, 2024 | 7.70 | +1.32 |
Anglogold Ashanti | AU | Sep 19, 2024 | 27.58 | +1.14 |
Anheuser-Busch InBev ADR | BUD | Sep 19, 2024 | 63.80 | +0.62 |
ANI Pharmaceuticals | ANIP | Sep 19, 2024 | 60.38 | -1.10 |
Anika Therapeutics | ANIK | Sep 19, 2024 | 25.36 | -0.43 |
Anixa Biosciences | ANIX | Sep 19, 2024 | 3.42 | -0.87 |
Annaly Capital Management | NLY | Sep 19, 2024 | 20.80 | -0.10 |
Annaly Capital Management F Pref | NLY-F | Sep 19, 2024 | 25.56 | +0.24 |
Annaly Capital Management G Pref | NLY-G | Sep 19, 2024 | 25.32 | +0.44 |
Annaly Capital Management I Pref | NLY-I | Sep 19, 2024 | 25.60 | +0.43 |
Annexon | ANNX | Sep 19, 2024 | 7.03 | +1.37 |
Annovis Bio | ANVS | Sep 19, 2024 | 8.64 | +3.35 |
ANSYS | ANSS | Sep 19, 2024 | 322.29 | +2.84 |
Antelope Enterprise | AEHL | Sep 19, 2024 | 1.02 | -7.27 |
Anterix | ATEX | Sep 19, 2024 | 39.55 | +1.75 |
Antero Midstream | AM | Sep 19, 2024 | 14.58 | -2.67 |
Antero Resources | AR | Sep 19, 2024 | 27.25 | +2.25 |
Anywhere Real Estate | HOUS | Sep 19, 2024 | 5.80 | +4.13 |
Aon | AON | Sep 19, 2024 | 346.97 | -0.67 |
APA | APA | Sep 19, 2024 | 25.36 | +1.00 |
Apartment Investment and Management | AIV | Sep 19, 2024 | 9.29 | +0.32 |
Apellis Pharmaceuticals | APLS | Sep 19, 2024 | 36.73 | +3.09 |
APi Group | APG | Sep 19, 2024 | 35.80 | +3.11 |
Apogee Enterprises | APOG | Sep 19, 2024 | 69.53 | +3.05 |
Apogee Therapeutics | APGE | Sep 19, 2024 | 52.95 | -0.73 |
Apollo Commercial Real Estate Finance | ARI | Sep 19, 2024 | 9.81 | +1.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.